Hjem
Per Sigvald Bakkes bilde

Per Sigvald Bakke

Dekan, Det medisinske fakultet
  • E-postPer.Bakke@uib.no
  • Telefon+47 55 58 20 87+47 992 04 032
  • Besøksadresse
    Armauer Hansens Hus
    Haukelandsveien 28
    Rom 
    407, 4. etasje
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2017). Variable susceptibility to cigarette smoke-induced emphysema in 34 inbred strains of mice implicates Abi3bp in emphysema susceptibility. American Journal of Respiratory Cell and Molecular Biology. 367-375.
  • Vis forfatter(e) (2017). U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics. Journal of Allergy and Clinical Immunology. 1797-1807.
  • Vis forfatter(e) (2017). The association of tidal EFL with exercise performance, exacerbations, and death in COPD. The International Journal of Chronic Obstructive Pulmonary Disease. 2179-2188.
  • Vis forfatter(e) (2017). Sex-based genetic association study identifies celsr1 as a possible chronic obstructive pulmonary disease risk locus among women. American Journal of Respiratory Cell and Molecular Biology. 332-341.
  • Vis forfatter(e) (2017). Randomised comparison of needle aspiration and chest tube drainage in spontaneous pneumothorax. European Respiratory Journal. 1-9.
  • Vis forfatter(e) (2017). Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. Human Molecular Genetics. 1584-1596.
  • Vis forfatter(e) (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes. Nature Genetics. 1126-1132.
  • Vis forfatter(e) (2017). Incidence of non-pulmonary cancer and lung cancer by amount of emphysema and airway wall thickness: A community-based cohort. European Respiratory Journal. 1-8.
  • Vis forfatter(e) (2017). Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD. European Respiratory Journal. 1-10.
  • Vis forfatter(e) (2017). Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis. 336-346.
  • Vis forfatter(e) (2017). Genome-wide association study of the genetic determinants of emphysema distribution. American Journal of Respiratory and Critical Care Medicine. 757-771.
  • Vis forfatter(e) (2017). Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nature Genetics. 416-425.
  • Vis forfatter(e) (2017). Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nature Genetics. 426-432.
  • Vis forfatter(e) (2017). Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects. American Journal of Respiratory Cell and Molecular Biology. 35-46.
  • Vis forfatter(e) (2017). Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients. Respiratory Research. 1-9.
  • Vis forfatter(e) (2017). Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease. European Respiratory Journal. 1-12.
  • Vis forfatter(e) (2017). A simple algorithm for the identification of clinical COPD phenotypes. European Respiratory Journal. 1-11.
  • Vis forfatter(e) (2016). Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study. Respiratory Research. 1-21.
  • Vis forfatter(e) (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. Respiratory Medicine. 53-59.
  • Vis forfatter(e) (2016). Oxygen desaturation in 6-min walk test is a risk factor for adverse outcomes in COPD patients. European Respiratory Journal. 82-91.
  • Vis forfatter(e) (2016). Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer. BMC Cancer.
  • Vis forfatter(e) (2016). Macrophage migration inhibitory factor, a role in COPD. American Journal of Physiology - Lung cellular and Molecular Physiology. L1-L7.
  • Vis forfatter(e) (2016). Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. The International Journal of Chronic Obstructive Pulmonary Disease. 2099-2108.
  • Vis forfatter(e) (2016). Global lung function initiative 2012 reference equations for spirometry in the Norwegian population. European Respiratory Journal. 1602-1611.
  • Vis forfatter(e) (2016). Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients. European Clinical Respiratory Journal.
  • Vis forfatter(e) (2016). Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study. Respiratory Medicine. 87-95.
  • Vis forfatter(e) (2016). Change in Pulmonary Diffusion Capacity in a General Population Sample over 9 Years. European Clinical Respiratory Journal. 9 sider.
  • Vis forfatter(e) (2016). A genome-wide analysis of the response to inhaled β 2-agonists in chronic obstructive pulmonary disease. The Pharmacogenomics Journal. 326-335.
  • Vis forfatter(e) (2015). Variability of within-breath reactance in COPD patients and its association with dyspnoea. European Respiratory Journal. 625-634.
  • Vis forfatter(e) (2015). The relationship of educational attainment with pulmonary emphysema and airway wall thickness. Annals of the American Thoracic Society. 813-820.
  • Vis forfatter(e) (2015). Serial measurements of arterial oxygen tension are associated with mortality in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 287-294.
  • Vis forfatter(e) (2015). Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study. Respiratory Medicine. 1138-1146.
  • Vis forfatter(e) (2015). Peak oxygen uptake and breathing pattern in COPD patients - a four-year longitudinal study. BMC Pulmonary Medicine.
  • Vis forfatter(e) (2015). One-year change in health status and subsequent outcomes in COPD. Thorax. 420-425.
  • Vis forfatter(e) (2015). Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): A genetic association study in UK Biobank. The Lancet Respiratory Medicine. 769-781.
  • Vis forfatter(e) (2015). Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: A pooled analysis of individual patient data. The Lancet Respiratory Medicine. 443-450.
  • Vis forfatter(e) (2015). Is sense of coherence a predictor of lifestyle changes in subjects at risk for type 2 diabetes? Public Health. 155-161.
  • Vis forfatter(e) (2015). Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Annals of the American Thoracic Society. 303-312.
  • Vis forfatter(e) (2015). Genetic control of gene expression at novel and established chronic obstructive pulmonary disease loci. Human Molecular Genetics. 1200-1210.
  • Vis forfatter(e) (2015). Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. European Respiratory Journal. 60-75.
  • Vis forfatter(e) (2015). Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations. PLOS ONE.
  • Vis forfatter(e) (2015). A genome-wide association study of emphysema and airway quantitative imaging phenotypes. American Journal of Respiratory and Critical Care Medicine. 559-569.
  • Vis forfatter(e) (2015). A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genetics.
  • Vis forfatter(e) (2014). Susceptibility to chronic mucus hypersecretion, a genome wide association study. PLOS ONE.
  • Vis forfatter(e) (2014). Risk loci for chronic obstructive pulmonary disease: A genome-wide association study and meta-analysis. The Lancet Respiratory Medicine. 214-225.
  • Vis forfatter(e) (2014). Predictors of health-related quality of life changes after lifestyle intervention in persons at risk of type 2 diabetes mellitus. Quality of Life Research. 2585-2593.
  • Vis forfatter(e) (2014). Predictors of exacerbations in chronic obstructive pulmonary disease - results from the Bergen COPD Cohort Study. PLOS ONE.
  • Vis forfatter(e) (2014). Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up. COPD: Journal of Chronic Obstructive Pulmonary Disease. 531-538.
  • Vis forfatter(e) (2014). Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease. Respirology (Carlton South. Print). 730-734.
  • Vis forfatter(e) (2014). On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. Bioinformatics. 157-164.
  • Vis forfatter(e) (2014). No impact of early real-time PCR screening for respiratory viruses on length of stay and use of antibiotics in elderly patients hospitalized with symptoms of a respiratory tract infection in a single center in Norway. European Journal of Clinical Microbiology and Infectious Diseases. 359-364.
  • Vis forfatter(e) (2014). Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respiratory Research.
  • Vis forfatter(e) (2014). Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 718-723.
  • Vis forfatter(e) (2014). Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Respiratory Research.
  • Vis forfatter(e) (2014). Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology. 678-687.
  • Vis forfatter(e) (2014). Beyond GWAS in COPD: Probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks. Human Heredity. 131-139.
  • Vis forfatter(e) (2014). Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients. Physiological Reports.
  • Vis forfatter(e) (2013). Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly. Clinical Respiratory Journal. 245-252.
  • Vis forfatter(e) (2013). Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 10 sider.
  • Vis forfatter(e) (2013). Insomnia symptoms, objectively measured sleep, and disease severity in chronic obstructive pulmonary disease outpatients. Sleep Medicine. 1328-1333.
  • Vis forfatter(e) (2013). Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respiratory Medicine. 1376-1384.
  • Vis forfatter(e) (2013). Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. European Respiratory Journal. 636-646.
  • Vis forfatter(e) (2013). Changes in body composition in patients with chronic obstructive pulmonary disease: do they influence patient-related outcomes? Annals of Nutrition and Metabolism. 239-247.
  • Vis forfatter(e) (2010). Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nature Genetics. 200-202.
  • Vis forfatter(e) (2010). Transthoracic fine-needle aspiration in the aetiological diagnosis of communityacquired pneumonia. Clinical Microbiology and Infection (CMI). 909-911.
  • Vis forfatter(e) (2010). Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • Vis forfatter(e) (2010). Systemic inflammatory markers in chronic obstructive pulmonary disease – results from the Bergen COPD Cohort Study. European Respiratory Journal. 540-548.
  • Vis forfatter(e) (2010). Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. American Journal of Respiratory and Critical Care Medicine. 353-359.
  • Vis forfatter(e) (2010). HRQoL changes, mood disorders and satisfaction after treatment in an unselected population of patients with lung cancer. Clinical Respiratory Journal. 168-175.
  • Vis forfatter(e) (2010). Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 480-485.
  • Vis forfatter(e) (2010). Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal. 89-96.
  • Vis forfatter(e) (2010). A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respiratory Medicine. 986-994.
  • Vis forfatter(e) (2009). Systemic mannose-binding lectin is not associated with chronic obstructive pulmonary disease. Respiratory Medicine. 283-290.
  • Vis forfatter(e) (2009). Relationships between hand-rolled cigarettes and primary lung cancer: A Norwegian experience. Clinical Respiratory Journal. 152-160.
  • Vis forfatter(e) (2009). Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking. European Respiratory Journal. 858-865.
  • Vis forfatter(e) (2009). Quantitative CT Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine.
  • Vis forfatter(e) (2009). Prevalens av hjemmerespiratorbehandling i Norge. Tidsskrift for Den norske legeforening. 2094-2097.
  • Vis forfatter(e) (2009). Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work, Environment and Health. 454-460.
  • Vis forfatter(e) (2009). Effect of reducing indoor air pollution on women’s respiratory symptoms and lung function: The RESPIRE Randomized Trial, Guatemala. American Journal of Epidemiology. 211-220.
  • Vis forfatter(e) (2009). Case–control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clinical Respiratory Journal.
  • Vis forfatter(e) (2009). CTLA4 gene polymorphisms are associated with chronic bronchitis. European Respiratory Journal. 598-604.
  • Vis forfatter(e) (2009). Aspects of healthcare utilisation in self-reported obstructive lung disease. Clinical Respiratory Journal. 34-41.
  • Vis forfatter(e) (2009). A genome-wide association study in chronic obstructive pulmonary disease (COPD): Identification of two major susceptibility loci. PLoS Genetics. 8 sider.
  • Vis forfatter(e) (2008). Respiratory symptoms, COPD severity, and health related quality of life in a general population sample. Respiratory Medicine. 399-406.
  • Vis forfatter(e) (2008). Repeatability of health economic data in COPD. Respiratory Medicine. 1556-1562.
  • Vis forfatter(e) (2008). Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates. Clinical Respiratory Journal. 10-25.
  • Vis forfatter(e) (2008). No increase in response rate by adding a web response option to a postal population survey: A randomized trial. Journal of Medical Internet Research. e40.
  • Vis forfatter(e) (2008). Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Respiratory Medicine. 1460-1467.
  • Vis forfatter(e) (2008). Designing studies for diagnostic tests. Clinical Respiratory Journal. 72-75.
  • Vis forfatter(e) (2008). Clinical data discriminating between adults with positive and negative results on bronchodilator testing. The International Journal of Tuberculosis and Lung Disease. 205-213.
  • Vis forfatter(e) (2008). Asthma and health-related quality of life - effect of adjusting for potential confounders. Clinical Respiratory Journal. 106-115.
  • Vis forfatter(e) (2007). The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. American Journal of Respiratory and Critical Care Medicine. 167-173.
  • Vis forfatter(e) (2007). Exposure to environmental tobacco smoke in a general population. Respiratory Medicine. 277-285.
  • Vis forfatter(e) (2007). Delays in the diagnostic pathways for primary pulmonary carcinoma in Southern Norway. Respiratory Medicine. 1251-1257.
  • Vis forfatter(e) (2006). Opplæring av pasienter i riktig bruk av inhalasjonsmedisiner. Tidsskrift for Den norske legeforening. 312-314.
  • Vis forfatter(e) (2006). Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. European Respiratory Journal. 682-688.
  • Vis forfatter(e) (2006). Does smoking cessation improve quality of life in patients with coronary heart disease? Scandinavian Cardiovascular Journal. 11-16.
  • Vis forfatter(e) (2006). Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 274-280.
  • Vis forfatter(e) (2005). The adult incidence of asthma and respiratory symptoms by passive smoking in utero or in childhood. American Journal of Respiratory and Critical Care Medicine. 61-66.
  • Vis forfatter(e) (2005). Scandinavian COPD research symposium. Respiratory Medicine.
  • Vis forfatter(e) (2005). Røykevaner blant medisinstudenter i Bergen. Tidsskrift for Den norske legeforening. 276-277.
  • Vis forfatter(e) (2005). Predictors of smoking cessation in patients admitted for acute coronary heart disease. Journal of Cardiovascular Risk. 472-477.
  • Vis forfatter(e) (2005). Indoor exposures and respiratory symptoms in a Norwegian community sample. Thorax. 937-942.
  • Vis forfatter(e) (2005). Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. The International Journal of Tuberculosis and Lung Disease. 926-932.
  • Vis forfatter(e) (2005). Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 842-847.
  • Vis forfatter(e) (2005). Et tverrfaglig undervisningsopplegg om obstruktiv lungesykdom i allmennpraksis. Tidsskrift for Den norske legeforening. 465-465.
  • Vis forfatter(e) (2005). Assessment of lung volumes in children and adolescents: comparison of two plethysmographic techniques. Clinical Physiology and Functional Imaging. 62-68.
  • Vis forfatter(e) (2000). Work related asthma: prevalence estimates by sex, age and smoking habits in a community sample. The International Journal of Tuberculosis and Lung Disease. 649-656.
  • Vis forfatter(e) (2000). Study design. European Respiratory Monograph. 128-153.
  • Vis forfatter(e) (2000). Snakker helsepersonell med småbarnsforeldre om passiv røyking? Tidsskrift for Den norske legeforening. 1616-1621.
  • Vis forfatter(e) (2000). Smoking status, disease duration, and educational level in females, are related to asthma school participation. European Respiratory Journal. 1022-1025.
  • Vis forfatter(e) (2000). Prevention of death from asthma. International Review of Asthma. 50-58.
  • Vis forfatter(e) (2000). Performance of population-specific Job exposure-matrices (JEM). Occup Environ Med. 126-132.
  • Vis forfatter(e) (2000). Patient satisfaction with healthcare in asthmatics and patients with COPD before and after patient education. Respiratory Medicine. 1057-1064.
  • Vis forfatter(e) (2000). Obstructive lung disease in patients within the hospital in the Nordic countries. European Respiratory Review. 428-431.
  • Vis forfatter(e) (2000). Norwegian population-based studies: risk factors for decrease in lung function; morbidity and mortality for obstructive lung disease. European Respiratory Review. 457-462.
  • Vis forfatter(e) (2000). Nonpharmacological intervention in obstructive lung disease. European Respiratory Review. 391-392.
  • Vis forfatter(e) (2000). Impact of patient education and self-management on morbidity in asthmatics and patients with COPD. Respiratory Medicine. 279-287.
  • Vis forfatter(e) (2000). Et forsvarlig blikk på bupropion. Lungeforum. 113-115.
  • Vis forfatter(e) (2000). Comparison of respiratory symptoms questionaires. The International Journal of Tuberculosis and Lung Disease. 83-90.
  • Vis forfatter(e) (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. American Journal of Respiratory and Critical Care Medicine. S:A562.
  • Vis forfatter(e) (1999). The association of sex, age and smoking to respiratory symptoms in a longitudinal study in western Norway. European Respiratory Journal. 19.
  • Vis forfatter(e) (1999). Reproducibility of indoor environment characteristics obtained in a walk through questionaire. A pilot study. Indoor Air: International Journal of Indoor Environment and Health. 26-32.
  • Vis forfatter(e) (1999). Relationship between two biological inflammatory markers and single-breath transfer factor for carbon monoxide (TLCO) in a general population sample. European Respiratory Journal. 133.
  • Vis forfatter(e) (1999). New epidemiological interpretations of the average attributable fraction from a game theoretical perspective. American Journal of Respiratory and Critical Care Medicine. S:A320.
  • Vis forfatter(e) (1999). Incidence and remission rates of respiratory symptoms by sex, age and smoking in a Norwegian community during twelve years. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • Vis forfatter(e) (1999). Decreasing response to respiratory disease surveys. Norwegian Respiratory Journal. 12.
  • Vis forfatter(e) (1999). Comparison between two respiratory symptomquestionnaires, by sex and smoking habits. American Journal of Respiratory and Critical Care Medicine. S:A134.
  • Vis forfatter(e) (1999). Asthma and wheezing are increasing in repeated community surveys of adults. European Respiratory Journal. 216.
  • Vis forfatter(e) (1999). Acute hospital treatment of obstructive lung disease in western Norway. Norwegian Respiratory Journal. 39.
  • Vis forfatter(e) (1998). Smokers, highly educated women and stable asthmatics do not want to participate in an asthma school. European Respiratory Journal. 404-404.
  • Vis forfatter(e) (1998). Serum inflammatory markers and level of carbon monoxide diffusion capacity in a general population sample. American Journal of Respiratory and Critical Care Medicine.
  • Vis forfatter(e) (1998). Relationship between single-breath transfer factor for carbon monoxide (TLCO) and airflow obstruction. European Respiratory Journal. 52.
  • Vis forfatter(e) (1998). Medikamentvaner og kunnskap om egen sykdom blant pasienter med obstruktiv lungesykdom. Tidsskrift for Den norske legeforening. 2006-2010.
  • Vis forfatter(e) (1998). Immunoglobulin E, viral antibodies and obstructive lung disease in adults. The relation between antibody level in serum, lung function and non-specific bronchial reactivity. Tidsskrift for Den norske legeforening. 1542-1547.
  • Vis forfatter(e) (1998). Immunglobulin E, virusantistoffer og obstruktiv lungesykdom hos voksne. Forholdet mellom antistoffnivå i serum, lungefunksjon og uspesifikk bronkial reaktivitet. Tidsskrift for Den norske legeforening. 1542-1547.
  • Vis forfatter(e) (1998). Hvorfor øker forekomsten av astma i Norge? Lungeforum. 169-169.
  • Vis forfatter(e) (1998). Applicability of the single breath carbon monoxide diffusing capacity in a Norwegian community study. American Journal of Respiratory and Critical Care Medicine. 1745-1750.
  • Vis forfatter(e) (1997). Transcutaneous abdominal ultrasonography in the staging of lung cancer. Thorax. 276-280.
  • Vis forfatter(e) (1997). Smoking and ulcer perforation. Gut. 177-180.
  • Vis forfatter(e) (1997). Smoking and ulcer perforation. Gut. 177-180.
  • Vis forfatter(e) (1997). Astma og inneklima i Hordaland. AstmaAllergi. 37.
  • Vis forfatter(e) (1996). Serum respiratory virus antibodies: Predictor of reduced one second forced expiratory volume in Norwegian adults. International Journal of Epidemiology. 134-141.
  • Vis forfatter(e) (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. European Respiratory Journal. 919-925.
  • Vis forfatter(e) (1996). Serum house dust mite antibodies: Predictor of increased bronchial responsiveness in adults of a community. European Respiratory Journal. 919-925.
  • Vis forfatter(e) (1996). Associations of forced expiratory volume in one second to serum total IgE and respiratory virus antibodies in subexamples of a general population. American Journal of Epidemiology. 134-141.
  • Vis forfatter(e) (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy. 682-689.
  • Vis forfatter(e) (1995). Total serum IgE and FEV%b by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clinical and Experimental Allergy. 582-689.
  • Vis forfatter(e) (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • Vis forfatter(e) (1995). Serum House-Dust-Mite Antibodies and Reduced FEV%b in adults of a Norwegian community. American Journal of Respiratory and Critical Care Medicine. 1158-1163.
  • Vis forfatter(e) (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • Vis forfatter(e) (1995). Respiratory virus antibodies in adults of a Norwegian community: prevalences and risk factors. International Journal of Epidemiology. 223-231.
  • Vis forfatter(e) (1995). Husstøvmidd sensibilisering: gir det nedsatt lungefunksjon og økt bronkial aktivitet hos voksne? Allergologen. 16-23.
  • Vis forfatter(e) (1994). Total and specific serum IgE levels in adults: relationship to sex, age and environemental factors. Clinical and Experimental Allergy. 530-539.
  • Vis forfatter(e) (1994). Total and specific immunoglobulin E-levels in a general adult population. Relationship to sex, age and environmental factors. Clinical and Experimental Allergy. 530-539.
  • Vis forfatter(e) (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • Vis forfatter(e) (1993). Obstruktive lungesykdommer hos voksne. Forekomst og årsaksfaktorer. Norsk Epidemiologi. 8-11.
  • Vis forfatter(e) (1993). Association of airflow impairment to level of serum IgE and number of respiratory virus antibodies in subsamples of a general population. The European respiratory journal. Supplement. 393-393.
  • Vis forfatter(e) (1992). Single breath transfer factor for carbon monoxide in an asymptomatic population of never smokers. Thorax. 167-173.
  • Vis forfatter(e) (1992). Occupational airborne exposure of the general population of a Norwegian county. Scandinavian Journal of Work, Environment and Health. 44-51.
  • Vis forfatter(e) (1992). Non-specific challenge test for the diagnosis of asthma in a general population sample. European Respiratory Journal. 644-644.
  • Vis forfatter(e) (1992). Astmatiske lungesykdommer. Astma- og allerginytt. 3435-3435.
  • Vis forfatter(e) (1992). Allergiske sykdommer i Norge. Operative definisjoner, forekomst og risikofaktorer. Nord Med. 108-109.
  • Vis forfatter(e) (1991). Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax. 863-870.
  • Vis forfatter(e) (1991). Occupational airborn exposure and respiratory disorders in a general population of Norway. European Respiratory Journal. 273-278.
  • Vis forfatter(e) (1991). Measurements of respiration symptoms and sample size to detect a given difference between treatment groups in obstructive lung disease. European Respiratory Review. 436-443.
  • Vis forfatter(e) (1991). Bronchial responsiveness in a Norwegian community. American Review of Respiratory Diseases. 317-322.
  • Vis forfatter(e) (1990). Smoking habits and lifetime occupational exposure to gases or dusts, including asbestos and quartz, in a Norwegian community. Scandinavian Journal of Work, Environment and Health. 195-202.
  • Vis forfatter(e) (1990). Postal survey on airborne occupational exposure and respiratory disorders in Norway. Causes and consequences of non-response. Journal of Epidemiology and Community Health. 316-320.
  • Vis forfatter(e) (1990). Hayfever, eczema and urticaria in south-west Norway. Lifetime prevalences and association with sex, age, occupational airborne exposures and respiratory symptoms. Allergy. European Journal of Allergy and Clinical Immunology. 515-522.
Vitenskapelig foredrag
  • Vis forfatter(e) (2017). Repeated desaturation in 6 minute walk test increases risk for mortality in COPD patients.
  • Vis forfatter(e) (2008). Cognitive behavioural therapy (CBT) for anxiety and depression in COPD: A treatment option in pulmonary care.
  • Vis forfatter(e) (2007). Virale pneumonier hos eldre.
  • Vis forfatter(e) (2007). Cognitive behavioral therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease.
  • Vis forfatter(e) (2004). Indoor air pollutions and respiratory symptoms in a Norwegian community sample.
  • Vis forfatter(e) (2003). The association between indoor climate and respiratory symptoms in a general population sample.
  • Vis forfatter(e) (2002). Prevalence and seveity of GOLD defined COPD in adults.
  • Vis forfatter(e) (2002). Long term changes in self-reported symptoms and diagnoses of obstructive lung disease and heart disease in Oslo, Norway.
  • Vis forfatter(e) (1999). The risks of snoring and day-time hypersomnolence in a general Norwegian population. Poster.
Sammendrag/abstract
  • Vis forfatter(e) (2020). Levels of proteinase 3 and neutrophil elastase in plasma, BAL and biopsies in COPD. European Respiratory Journal.
  • Vis forfatter(e) (2020). Changes in the induced sputum proteome during COPD exacerbations. European Respiratory Journal.
  • Vis forfatter(e) (2019). Repeated bronchoscopy examination of the airway microbiome. European Respiratory Journal.
  • Vis forfatter(e) (2019). Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels. European Respiratory Journal.
  • Vis forfatter(e) (2017). Static hyperinflation and decline in functional capacity in COPD patients. European Respiratory Journal.
  • Vis forfatter(e) (2016). Respiratory timing and dynamic hyperinflation during incremental exercise in patients with COPD. European Respiratory Journal.
  • Vis forfatter(e) (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal.
  • Vis forfatter(e) (2012). Hu antibodies are present in smokers with chronic obstructive pulmonary disease without cancer or neurological disease. Journal of Neuroimmunology. 21-22.
  • Vis forfatter(e) (2010). Testing for Weak Signal. Genetic Epidemiology. 938-939.
  • Vis forfatter(e) (2009). How expensive is comorbidity in COPD? Respiratory Medicine. S7-S7.
  • Vis forfatter(e) (2008). Group cognitive behavioural therapy for anxiety, depression and sleep disturbances in patients with chronic respiratory illness. International Journal of Psychology (IJP). 16-16.
  • Vis forfatter(e) (2007). Health related quality of life, mood disorders and coping abilities in an unselected sample of patients with primary lung cancer. Journal of Thoracic Oncology. S431-S431.
  • Vis forfatter(e) (2007). Cognitive behavioural therapy in groups for anxiety and depression in patients with chronic obstructive pulmonary disease. Journal of Psychosomatic Research. 323-323.
  • Vis forfatter(e) (2004). Chronic airway symptoms and lung function among women in a rural community in Guatemala with high indoor air pollution levels. Epidemiology. S79-S80.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2018). Large-scale label-free quantitative mapping of the sputum proteome. Journal of Proteome Research. 2072-2091.
  • Vis forfatter(e) (2016). Participation in research bronchoscopy: a literature review. European Clinical Respiratory Journal.
  • Vis forfatter(e) (2016). Complications and discomfort of bronchoscopy: a systematic review. European Clinical Respiratory Journal. 9 sider.
  • Vis forfatter(e) (2014). Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. American Journal of Respiratory and Critical Care Medicine. 1022-1030.
  • Vis forfatter(e) (2014). Lessons from ECLIPSE: A review of COPD biomarkers. Thorax. 666-672.
  • Vis forfatter(e) (2009). Genetikk ved kronisk obstruktiv lungesykdom. Tidsskrift for Den norske legeforening. 2104-2107.
  • Vis forfatter(e) (2005). The incidence of adult asthma: a review. The International Journal of Tuberculosis and Lung Disease. 603-612.

Se fullstendig oversikt over publikasjoner i CRIStin.